With the increase in the effectiveness of cryopreservation, the use of GnRH agonists with a "freeze all" approach so that embryos are transferred in subsequent cycles may be the ideal strategy to decrease or eliminate the prevalence of OHSS (Yılmaz et al., 2020). The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.